About ADC Biotechnology
ADC Biotechnology is a company based in Saint Asaph (United Kingdom) founded in 2010 was acquired by Sterling Pharma Solutions in April 2021. ADC Biotechnology has raised $16.16 million across 7 funding rounds from investors including Development Bank of Wales, Downing and Maven Capital Partners. The company has 38 employees as of March 31, 2022. ADC Biotechnology offers products and services including Prediksi Macau and Live Draw Macau. ADC Biotechnology operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Saint Asaph, United Kingdom
- Employees 38 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Adc Biotechnology Ltd
-
Annual Revenue
$2.11 M (USD)-2as on Apr 30, 2020
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.16 M (USD)
in 7 rounds
-
Latest Funding Round
Not available
-
Investors
Development Bank of Wales
& 10 more
-
Employee Count
38
as on Mar 31, 2022
-
Acquired by
Sterling Pharma Solutions
(Apr 07, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADC Biotechnology
ADC Biotechnology offers a comprehensive portfolio of products and services, including Prediksi Macau and Live Draw Macau.
Provides forecasts for Macau lottery numbers
Delivers real-time lottery draw updates
Funding Insights of ADC Biotechnology
ADC Biotechnology has successfully raised a total of $16.16M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ADC Biotechnology
ADC Biotechnology has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Development Bank of Wales, Downing and Maven Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Inheritance tax relief, funds, and bonds are provided across sectors.
|
Locked | Locked | Locked | |
|
BioScience Managers is engaged in healthcare investment and innovation.
|
Locked | Locked | Locked | |
|
Multiple sectors are targeted for private equity investments.
|
Locked | Locked | Locked |
Investor details for ADC Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ADC Biotechnology
Investment portfolio details for ADC Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ADC Biotechnology
Detailed financials for ADC Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adc Biotechnology Comparisons
Peer comparison for ADC Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ADC Biotechnology
ADC Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of ADC Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adc Biotechnology
Complete news archive for ADC Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ADC Biotechnology
ADC Biotechnology was founded in 2010.
ADC Biotechnology is headquartered in Saint Asaph, United Kingdom. It is registered at Saint Asaph, Denbighshire, United Kingdom.
ADC Biotechnology is a funded company, having raised a total of $16.16M across 7 funding rounds to date.
As of Mar 31, 2022, the latest employee count at ADC Biotechnology is 38.
Annual revenue of ADC Biotechnology is $2.11M as on Apr 30, 2020.
ADC Bio is developing antibody-drug conjugate (ADC). Its proprietary technology called Lock-Release involves conjugation of proteins that are immobilised on solid supports and delivers key product advantages from minimal aggregate formation to minimal residual free drug and enhanced yields. It also provides technical services including conjugation to a variety of toxin payloads, toxin-linker design and synthesis and supply of ADCs for proof of concept and toxicology testing.
ADC Biotechnology's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
ADC Biotechnology offers Prediksi Macau and Live Draw Macau.
ADC Biotechnology has 11 investors. Key investors include Development Bank of Wales, Downing, Maven Capital Partners, Sterling Pharma Solutions, and Welsh Government.